| 1. |
Wu TX, Li YP, Li J, et al. A milestone for clinical trials: the globalcl inical trial registration system lauched up. Chin J Evid-Based Med,2007, 7(7): 479-480.
|
| 2. |
Chang J, Li TQ, Wan MH, et al. Quality assessment for randomized controlled trials published in four acta of traditional Chinese medicine. Chin J Evid-Based Med, 2006, 6(3): 171-178.
|
| 3. |
中国循证医学杂志, 2006; 6(4): 297-304.
|
| 4. |
Mao B, Wang G, Chen XD, et al. Quality Assessment of the Reporting of Randomized Controlled Trials Published in the Chinese Journal of Integrated Traditional and Western Medicine with the Revised CONSORT Statement. Chin J Evid-Based Med, 2006, 6(4): 297-304.
|
| 5. |
The Journal of Evidence-based Medicine, 2005, 5(1): 26-28, 32.
|
| 6. |
Duan X, Zhou LK, Wu TX, et al. Quality Analysis of Literatures on Clinical Randomized Controlled Trial of Coronary Heart Diseases Treated with TCM. Chinese Journal of Integrated Traditional and Western Medicine, 2003, 23(3): 164-167.
|
| 7. |
Ni J, Chen XY, Zheng J. Comment on Literatures of Clinical Randomized Controlled Trials of Traditional Chinese Medicine for Acute Myocardial Infarction. Journal of Guangzhou University of Traditional Chinese Medicine, 2003, 20(1): 82-85.
|
| 8. |
Chen HY, Chen J, Wu TX, et al. Quality evaluation on methodology of clinical research of yinzhihuang injection in the treatment of icteric virus hepatitis. China Pharmacy, 2005, 16(13): 1031-1033.
|
| 9. |
Wang Q, Wu TX, Liu GJ. Quality evaluation for randomized controlled trials of traditional Chinese medicinal for unstable angina pectoris. Journal of Chengdu Unversity of Tarditional Chinese Medicine, 2003, 26(2): 52-55.
|
| 10. |
Wei JF, Qiao JQ, Ni J, et al. Quality Assessment for Randomized Controlled Trials of Traditional Chinese Medicinal Herbs in the Treatment of Acute Appear Respiratory Infection. West China Medical Journal, 2003, 18(3): 297-299.
|
| 11. |
http://www.chictr.org/Site/Question.aspx.
|
| 12. |
Human subjects research definitions. http://grants.nih.gov/grants/funding/phs398/instructions2/p2_human_subjects_definitions.htm.
|
| 13. |
世界医学大会赫尔辛基宣言, 人体医学研究的伦理准则, 2000年10月修改版.http://www.wma.net/policy/b3.htm.
|
| 14. |
Ottawa Statement. http://ottawagroup.ohri.ca/statement.html.
|
| 15. |
China and India join WHO clinical trial registry platform. http://www.who.int/mediacentre/news/releases/2007/pr41/en/index.html.
|
| 16. |
吴泰相, 李幼平, 李静, 等. 临床试验的里程碑事件: 全球临床试验注册制度建成运行. 中国循证医学杂志, 2007, 7(7): 479-80.
|
| 17. |
Angel is CD, Drazen JM, Frizelle FA, et al. Is This Cl inical Trial Fully Registered?: A Statement from the International Committee of Medical Journal Editors. http://www.icmje.org/clin_trialup.htm.
|
| 18. |
Moher D, Schulz KF, Altman D, et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA, 2001, 285(15): 1987-1991.
|
| 19. |
Campbell MK, Elbourne DR, Altman DG, et al. CONSORT statement: extension to cluster randomised trials. BMJ, 2004, 328(7441): 702-708.
|
| 20. |
Gagnier JJ, Boon H, Rochon P, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Annals of Internal Medicine, 2006;144(5): 364-367.
|
| 21. |
Moher D, Jones A, Lepage L, et al. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluaton? JAMA, 2001; 285(15):1992-1995.
|
| 22. |
吴泰相, 李幼平, 刘关键, 等. 临床试验注册制度与循证医学. 中国循证医学杂志, 2007, 7(4): 239-243. Wu TX, Li YP, Liu GJ, et al. Clinical trial registration system and evidence-based medicine. Chin J Evid-Based Med, 2007, 7(4): 239-243.
|
| 23. |
李幼平, 吴泰相, 刘关键, 等. 中国循证医学中心促进中医药现代化的策略. 中国循证医学杂志, 2007, 7(3): 159-161. Li YP, Wu TX, Liu GJ, et al. The strategy of chinese evidence-based medicine center for promoting the modernization of traditional Chinese medicine. Chin J Evid-Based Med, 2007, 7(3): 159-161.
|
| 24. |
Wu TX, Li YP, Bian ZX, et al. Randomized trials in China: How many are authentic? Cochrane Colloquium 14th, Dublin.
|
| 25. |
李廷谦, 王刚, 王蕾, 等. 我国中医药临床研究的现状和评价. 中国循证医学杂志, 2005, 5(6): 431-437. Li TQ, Wang G, Wang L, et al. Clinical trials of traditional chinese medicine in China: status and evaluation. Chin J Evid-Based Med, 2005, 5(6): 431-437.
|
| 26. |
李廷谦, 毛兵, 常静, 等. 中西医、中医核心杂志临床研究文献评价. 华西医学. 2000, 15(3): 266-269. Li TQ, Mao B, Chang J, et al. An evaluation of clinical research literatures in core journals of traditional Chinese medicine integrated with western medicine or traditional Chinese medicine. West China Medical Journal, 2000, 15(3): 266-269.
|
| 27. |
常静, 李廷谦, 万美华, 等. 中国4种中医药大学学报随机对照临床试验文献的质量评价. 中国循证医学杂志, 2006, 6(3): 171-178.
|
| 28. |
毛兵, 王刚, 陈小东, 等. 《中国中西医结合杂志》发表随机对照试验报告的质量评价.
|
| 29. |
温泽淮, 赖世隆, 梁伟雄, 等. 进一步改善中医药临床试验报告的质量. 中国中西医结合杂志, 2004, 24(11): 1022-1025. Wen ZH, Lai SL, Liang WX, et al. Further improve the reporting quality ofTCM clinical trials. Chinese Journal of Integrated Traditional and Western Medicine, 2004, 24(11): 1022-1025.
|
| 30. |
刘晓雁, 赖世隆, 刘鹏熙. 中医药及中西医结合治疗乳腺癌研究文献的质量评价. 循证医学, 2005, 5(1): 26-28, 32. Liu XY, Lai SL, Liu PX. Quality analysis ofliterature of traditional Chinese medicine or integrated traditional and western medicines on breast cancer.
|
| 31. |
韩丽琳, 黄旭春. 中医药治疗抑郁症研究文献的质量评价. 云南中医学院学报, 2005, 28(2): 8-10, 18. Han LL, Huang XC. Quality evaluation on treatment of depression with TCM by clinical document. Journal of Yunnan College of Chinese Medicine, 2005, 28(2): 8-10, 18.
|
| 32. |
段鑫, 周礼鲲, 吴泰相, 等. 中医药治疗冠心病的临床随机对照试验文献的质量分析. 中国中西医结合杂志, 2003, 23(3): 164-167.
|
| 33. |
倪娟, 陈小燕, 郑洁. 我国中医药治疗治疗急性心肌梗死临床试验文献的质量评价. 广州中医药大学学报, 2003, 20(1): 82-85.
|
| 34. |
陈辉扬, 陈军, 吴泰相, 等. 茵栀黄注射液治疗黄疸型病毒性肝炎临床研究的方法学质量评价. 中国药房. 2005, 16(13): 1031-1033.
|
| 35. |
许卫华, 谢红. 雷公藤制剂治疗类风湿关节炎随机对照试验文献方法学质量评价. 中华风湿病学杂志, 2004, 8(12): 740-742. Xu WH, Xie H. Methodological quality evaluation of randomized controlled trials in rheumatoid arthritist related with preparations of Tripterygium wilfordii. Chinese Journal of Rheumatology, 2004, 8(12): 740-742.
|
| 36. |
王覃, 吴泰相, 刘关键. 关于不稳定型心绞痛的中医药临床随机对照试验质量的评价. 成都中医药大学学报, 2003, 26(2): 52-55.
|
| 37. |
魏家富, 乔杰奇, 倪娟, 等. 关于上呼吸道感染的中医药临床随机对照试验的质量评价. 华西医学, 2003, 18(3): 297-299.
|
| 38. |
段宁, 王文梅. 从循证医学角度评价中医药治疗RAU相关文献. 江苏中医药, 2004, 25(7): 50-52.Duan N, Wang WM. Evidence-based evaluation of relevantliterature involving TCM treatment for RAU. Jiangsu Journal of Traditional Chinese Medicine, 2004, 25(7): 50-52.
|
| 39. |
卫茂玲, 辜蕊, 张鸣明, 等. 11种地方性中医药期刊1995～2000年临床研究文献质量的初步分析. 中国循证医学杂志, 2004, 4(6): 410-413. Wei ML, Gu R, Zhang MM, et al. A brief study on the quality of clinical trials in 11 medical journals of traditional Chinese medicine from 1995 to 2000. Chin J of Evid-Based Med, 2004, 4(6): 410-413.
|
| 40. |
许良智, 陈进, 王家良, 等. 部分中华医学会系列杂志防治性研究论文中随机问题的商榷. 中华医学杂志, 1999; 79(2): 97-98. Xu LZ, Chen J, Wang JL, et al. On the randomization methods used in the preventive and therapeutic studies published in some Chinese Medical Journal Series. National Medical Journal of China, 1999; 79(2): 97-98.
|
| 41. |
Tang JL, Zhan SY, Ernst E: Review of randomized controlled trials of traditional Chinese medicine. BMJ, 1999, 319: 160-161.
|
| 42. |
Bian ZX, Li YP, Moher D, et al . Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. Zhong Xi Yi Jie He Xue Bao, 2006, 4(2):120-129.
|
| 43. |
Bian ZX, Moher D, Dagenais S, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. Zhong Xi Yi Jie He Xue Bao, 2006, 4(2): 130-136.
|
| 44. |
Leung KS, Bian ZX, Moher D, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part III: quality control of Chinese herbal medicine used in randomized controlled trials. Zhong Xi Yi Jie He Xue Bao. 2006, 4(3): 225-232.
|
| 45. |
Bian ZX, Moher D, Dagenais S, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part IV: applying a revised CONSORT checklist to measure reporting quality. Zhong Xi Yi Jie He Xue Bao, 2006, 4(3): 233-242.
|
